Is Nexaph legit? It shares lab results with EZ and Ameano

Nexaph is a working shop with Janoshik results you can look up, but those results are not Nexaph's alone. On 10 October 2026 the lab pages of Nexaph, EZ Peptides and Ameano Peptides showed one SS-31 batch under three prefixes, with identical vial figures on Janoshik tasks 163730, 163731 and 163732. That points to a shared supply of tested product. It does not show who owns the three shops. Finnrick's July report gives Nexaph a 60% pass rate across 253 of its own tests.

Buyers have suspected a link for months. A Peptide Critic thread from 29 April 2026 compared a Nexaph and an EZ GHK-Cu report and found "the same images and the same test date and the same exact purity". Finnrick, which sells paid vendor reports, published a 31-page report on Nexaph on 3 July 2026. This page sets out what we could re-check ourselves and labels what we could not.

What do the three storefronts say about themselves?

Each names a different entity, in a different place.

Registrant details are redacted for all three domains, and each uses a different pair of Cloudflare nameservers. The legal pages do not share text. We compared EZ's privacy policy with Nexaph's and Ameano's privacy, terms and refund pages; no pair of brands shared even 5% of its eight-word sequences. EZ's address sits in New Mexico while its phone number carries an Indianapolis area code, a mismatch another reviewer noted in August.

The one shared naming habit is the code-name scheme. Nexaph sells tirzepatide as "NXP-2P", EZ as "EZP-2P" and Ameano as "AMP-2P". Our piece on code-name catalogs covers why sellers use them.

Do they publish the same lab results?

Yes, for at least three products. Each brand runs a lab-results site (testing.nexaph.com, testing.ezpeptides.com, testing.ameanopeptides.com) that takes a batch code and returns the Janoshik task number, verification key and figures. We pulled the same batches from all three on 10 October 2026, starting with an SS-31 30 mg batch.

Each report has its own verification key.

Two runs of three vials do not land on the same three masses to the hundredth of a milligram and the same purities to the thousandth of a percent. Our reading, which is inference: each row group is one analysis issued as several reports.

Janoshik sells this service. An August 2026 write-up of a discussion between labs says Janoshik lists an additional report under a separate client name at €35 and changes only the header and client name, not the laboratory ID. The task numbers above do change. Either the practice differs from that description or these copies went through another route, and we could not tell which from outside.

We could not open the Janoshik pages to confirm the client name printed on each report. On 10 October 2026, verify.janoshik.com returned a Cloudflare block to our requests from two networks. Our own Janoshik mirror, last crawled 30 June 2026, holds no report naming any of the three brands. The figures above are therefore what the brands' own lab pages display, keyed to task numbers you can check on janoshik.com.

EZ and Ameano share batch codes and prices

EZ Peptides and Ameano sell several products only a small set of shops carry. On 10 October 2026, the product pages listed these batch codes and prices.

Four of five match on batch and price. On the fifth, EZ and Ameano list different batches. Ameano's product page prints its batch in lower case, and that string returned "results coming soon" on its lab page. Typed in capitals, AMP-2P6008042026-03 returned four published tests with the same vial figures as Nexaph's NXP-2P6008042026-03, so Nexaph and Ameano share that batch too.

One more detail for EZ buyers: its Adamax and Bronchogen product pages both link a Janoshik report whose file name reads "Cartalax_10mg".

What about the identical affiliate portals?

partners.ezpeptides.com and partners.ameanopeptides.com both returned the same 7,389-byte "Affiliate Portal" page on 10 October 2026, with the same SHA-256 hash. That looks like a strong link until you check the DNS. Both names point to partners.goaffpro.com, and GoAffPro's own portal at affiliates.goaffpro.com returns the identical file. Any store on that platform would match. Nexaph's /affiliate path returned a 404, and we found no GoAffPro script on its homepage.

The site code offers one narrower overlap. All three storefronts load the same 38,993-byte script from a plugin called Research Gate Pro, an age and research-use gate. EZ and Ameano also load the same 108,645-byte rewards widget from a plugin called SwiftCS Rewards. Neither plugin appears in the WordPress.org directory.

A private plugin shared by three shops points to a common developer or a common source of site builds. It does not tell us who runs the shops, and the developer may sell the plugin to others. All three also load BTCPay, a crypto checkout plugin. We did not go through checkout, so we have not seen the payment descriptors.

What does Finnrick's report say?

Finnrick published "Vendor Intelligence Report: Nexaph" on 3 July 2026. The first four pages are free; we read those, not the full 31 pages. In its own words, the report:

• "maps same-operator evidence for EZ Peptides, an operator-linked IRON Peptides branch, and non-canonical Nexaph-branded domains";
• cites "a reported Nexaph discount-code signup returning an EZ Peptides coupon email";
• lists "evidence of cloned Janoshik COAs across Nexaph/EZ Peptides/Ameano";
• says site materials name Shanghai Nexa Pharma Co but "searched U.S. registries did not produce a matching registration";
• reports a 60% pass rate across 253 Finnrick lab tests, and a tirzepatide batch that "reportedly failed sterility".

The free pages name Ameano only in the certificate line. The same-operator finding covers Nexaph and EZ. We have not seen Finnrick's underlying evidence for either, the coupon email, or the sterility certificate, so we report those as Finnrick's claims. Finnrick's vendor page for Nexaph listed 291 tests when we read it on 10 October.

Forum posters describe the relationship in looser terms. In a May 2026 Peptide Critic thread, one called the two "sister companies" and said Nexaph once sent single-vial buyers to EZ. Another wrote that "Nexaph sells kits / EZ sell singles". We could not confirm the old link; Nexaph's homepage on 10 October did not mention EZ or Ameano.

So are they the same company?

The record supports two statements, and not a third.

1. Same tested material. Three brands display one SS-31 analysis and one tirzepatide analysis under their own names. EZ and Ameano carry the same batch codes and prices on four products. We can show this, and you can re-check it.
2. Shared site plumbing. Three shops run the same unlisted gate plugin, and two run the same unlisted rewards plugin.
3. Common ownership: not shown. Three entities in three places, with different domain dates, nameservers and legal text. Finnrick says it has same-operator evidence for Nexaph and EZ; we have not seen it.

A wholesaler that sells to resellers and pays the lab for copies under each client's name would produce points 1 and 2. So would one operator with three storefronts. Why peptide vendors run alias clusters explains why the second arrangement is common, and our data on Reta One Labs and three other brands shows the same certificate pattern at Kovera.

What this means if you buy from one of them

• One report, three logos. If you compare the three brands by testing record, count the SS-31 and tirzepatide analyses once.
• Match your batch, not the product page. Look up the code printed on your vial on the brand's lab page, then check the task number at janoshik.com. Our guide to verifying a Janoshik COA has the steps.
• Type the batch code in capitals. Ameano's lab page returned "results coming soon" for its 60 mg tirzepatide batch in lower case, as the product page prints it, and four published tests for the same code in capitals.

What we read

The homepages, about, contact and legal pages of nexaph.com, ezpeptides.com and ameanopeptides.com; product pages for SS-31, the Deadpool blend, Adamax, Bronchogen, GHK-Cu and tirzepatide 60 mg; the testing subdomains for the batches in the tables; partners.ezpeptides.com, partners.ameanopeptides.com and affiliates.goaffpro.com, with SHA-256 hashes; RDAP for all three domains; DNS for the partner, coa and testing subdomains; Finnrick's free report pages and vendor pages; two Peptide Critic threads. All read 10 October 2026, except the threads (posted April and May 2026).

What we did not read

Finnrick's full 31-page report, and the Janoshik report pages themselves, which blocked our requests. New Mexico, Arkansas, Indiana or Florida business registries. Checkout and payment pages.

We did not contact the three companies, Finnrick or Janoshik for this piece.

Sources

• Finnrick, Vendor Intelligence Report: Nexaph, 3 July 2026 (free pages)
• Finnrick, Nexaph vendor page, read 10 October 2026
• Nexaph lab results, SS-31 batch NXP-ATP3005072026-01 and tirzepatide batch NXP-2P6003282026-02
• EZ Peptides lab results, EZP-ATP3005072026-01, EZP-2P6003282026-02, EZP-BRON1007222026-01
• Ameano lab results, AMP-ATP3005072026-01, AMP-2P6003282026-02, BRON1007222026-01
• Janoshik verification - enter the task number and key
• Substack, Same Vial. Three Labels. Three COAs., 17 August 2026
• Peptide Critic Community, Thoughts on duplicate COAs, 29 April 2026, and Ezpeptide and Nexaph Janoshik test results, May 2026
• Peptides Enhanced, Is EZ Peptides legit?, 13 August 2026
• RDAP lookup for nexaph.com, ezpeptides.com and ameanopeptides.com